Antibiotics are losing their power: What ICMR’s latest report reveals about India’s growing resistance crisis

Antibiotic resistance, ICMR report 2026: ICMR's latest report highlights India's growing antibiotic resistance crisis, revealing how common bacterial infections are becoming increasingly difficult to treat effectively.

inscript
4 min read
Recent ICMR report on the growing threat of resistance to last-resort antibiotics in India.

Recent ICMR report on the growing threat of resistance to last-resort antibiotics in India.

For many decades, antibiotics have ranked among the most vital tools in modern medicine. From curing urinary tract infections to aiding recovery after major surgeries, these drugs have turned once-dangerous bacterial infections into conditions that can be treated. But what occurs when the medicines themselves cease to be effective?

India is confronting exactly this problem. A new report from the Indian Council of Medical Research (ICMR) has drawn attention to an alarming increase in antimicrobial resistance (AMR), as several common bacteria display reduced susceptibility to the antibiotics doctors routinely prescribe.

One result stands out. Just 18.4 per cent of the tested Escherichia coli (E. coli) isolates were susceptible to cefotaxime, an antibiotic that is commonly used. This figure means that in laboratory assessments, the medicine worked against fewer than one in five of the bacterial isolates tested.

These findings form part of ICMR's Antimicrobial Resistance Surveillance and Research Network (AMRSN) Annual Report 2025, which was released in November 2026. Beyond the figures, the report poses a broader question: is India moving towards a future in which even ordinary bacterial infections become harder and harder to treat?

What is antibiotic resistance, precisely?

To grasp how serious these findings are, one must understand the way antibiotics work.

Antibiotics are medications prescribed to treat bacterial infections. They either destroy bacteria or prevent them from reproducing. Yet bacteria are living organisms capable of developing ways to survive exposure to the medicines meant to eliminate them.

This phenomenon is called antimicrobial resistance.

Once bacteria develop resistance to a specific antibiotic, that medicine may no longer be able to halt their growth. As a result, an infection that was once treatable with an easily available medicine may now call for a different treatment.

Crucially, it is the bacteria that develop resistance, not the human body.

Resistance can arise naturally over time, but using antibiotics unnecessarily and inappropriately speeds up the process. Taking antibiotics without medical advice, using them for illnesses caused by viruses, and not following a doctor's prescribed treatment can all contribute to the problem.

What does the ICMR report reveal?

The 2025 report presents laboratory findings from 30 tertiary-care hospitals and 34 secondary-care hospitals across India.

113,008 culture positive isolates were obtained from tertiary care facilities and 20,529 from secondary care facilities. It is particularly significant that secondary care facilities were included in this study. Secondary care facilities can include district hospitals meaning we have a better picture of resistance in smaller hospitals.

E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii.

E. coli is naturally found in the gut of humans. Certain strains can cause infections. Urinary tract infections may occur. Severe septic infections can occur with some strains.

Only 18.4% of E. colis were sensitive to cefotaxime. Only 24.7% were sensitive to ceftazidime.

Fluoroquinolones

Only 9% of E. colis were sensitive to ciprofloxacin. Only 18.2% were sensitive to levofloxacin.

As a result, many commonly prescribed antibiotics are no longer very effective against specific strains of bacteria.

Even stronger antibiotics are facing resistance

Most concerning about this report is that resistance is not only occurring in commonly prescribed antibiotics.

Carbapenems are a strong antibiotic drug that is typically reserved for severe bacterial infections that may not be responding to other treatments.

Despite being strong drugs, resistance is increasing.

Only between 35-40% of Klebsiella pneumoniae isolates were sensitive to carbapenems. Only 29.2% were sensitive to piperacillin-tazobactam.

Klebsiella pneumoniae can cause lung infections, UTIs, blood infections and wound infections. It can be particularly concerning in a hospital environment. Critically ill patients may be immunocompromised.

Acinetobacter baumannii

Of the 360 revived isolates studied, 328 (91.1%) had resistance to carbapenems.

This is particularly concerning for intensive care units. Acinetobacter baumannii can cause severe hospital acquired infections.

If bacteria are resistant to the drugs typically used to treat complex infections, there may be fewer treatment options.

Is the problem spreading beyond major hospitals?

A particularly important change in this 2025 report is the inclusion of data from 34 secondary care facilities.

Previously, data was mainly collected from tertiary care facilities. Including data from secondary care facilities allows us to understand resistance in various healthcare facilities better.

Findings were not encouraging.

In secondary care facilities, resistance in E. coli to ceftriaxone has increased significantly from 39.8% in small facilities (<200 beds) to 11.5% in large facilities (>500 beds).

Resistance to ciprofloxacin was very high in all categories of secondary care facilities. Resistance ranged from 21% in small facilities to 6.2% in large facilities.

This suggests that resistance can differ greatly between healthcare facilities.

It is therefore important to perform local monitoring. Even if a drug is effective against a certain strain in one facility, it may not be effective at treating that same infection in a different facility.

Why is resistance increasing?

Inappropriate usage and overuse of antibiotics is a key reason for increasing resistance.

Antibiotics can be inappropriately used. Many common illnesses, for example the common cold, or most viral fevers, cannot be treated with antibiotics.

Despite this, people may inappropriately take antibiotics. Often, this may be done without consulting a doctor.

Dr Kamini Walia, Scientist G and head of the Division of Descriptive Research within ICMR, highlights that inappropriate use of antibiotics is a key cause of resistance.

She also stated in an interview with The Indian Express that poor infection control, poor hand hygiene and use of antibiotics in animals were contributing factors.

Poor diagnostic facilities and inappropriate prescriptions may also mean that it is difficult to accurately identify the bacteria causing an infection, and choose the best treatment.

Impact on Patients

Although antibiotic resistance is rising, it does not necessarily mean that all antibiotics have no effect, and all infections cannot be treated.

However, it does mean that certain infections may be harder to treat, as doctors may have fewer reliable treatments.

If common antibiotics are ineffective, more tests may be required. Alternative treatments may be required. Patients may be monitored for longer.

Alternative treatments may be more expensive and have increased side effects.

Certain groups may be particularly affected. Newborn babies, older people and critically ill patients may be more severely affected.

Klebsiella pneumoniae was the most common bacteria isolated from blood infections in neonates (0-28 days old), accounting for 25.1% of isolates in this group.

If a neonate is suspected to have sepsis, it is important to quickly diagnose and treat. If commonly prescribed antibiotics are ineffective due to resistance, it can cause difficulty in managing a very serious condition.

Can we prevent an antibiotic resistance crisis in India?

With regards to antibiotic resistance in India, it is clear that we must do more than simply develop stronger antibiotics. We must prioritise preventing infections, and preserving the effectiveness of current antibiotics.

Reliable testing facilities within hospitals to identify the bacteria causing an infection, and what antibiotics may work, should be available. Antimicrobial susceptibility testing can help doctors make treatment choices.

Strong antimicrobial stewardship programs should be in place within hospitals. This encourages appropriate antibiotic prescriptions and prevents powerful antibiotics from being unnecessarily used.

Improving sanitation, washing hands regularly, infection control in hospitals, and ensuring appropriate vaccinations can reduce the number of infections, meaning less antibiotics will be needed.

In general, it is extremely important to not consider antibiotics as common medicines. They should only be taken if necessary, and only under appropriate medical guidance.

Although this report shows that we are starting to lose effectiveness against certain bacterial infections, it does not mean that modern medicine has run out of solutions. It does however show that we are starting to lose effectiveness of some of the medications that are vital within modern healthcare.

Antibiotics have revolutionised medicine, meaning that dangerous infections can be treated. However, we must be careful that their inappropriate use does not mean we lose this progress.

Written by
inscript
inscript
19 Followers

Read more

India records 38% decline in TB mortality since 2015: What has changed and why is the fight far from over?

WHO Global TB Report 2026: India's tuberculosis death rate has declined by 38% since 2015, reflecting progress in diagnosis and treatment, but major challenges remain.

Can AI defeat cancer: Anthropic CEO predicts a medical revolution within a decade

Artificial Intelligence, Cancer Treatment: Could artificial intelligence transform cancer treatment within a decade? Anthropic CEO Dario Amodei's prediction raises hopes and questions about medicine's future.

“No fear, No fear!” How Diwali night turned into a nightmare for children with Autism

impact of noise pollution on children with autism: The incessant bursting of firecrackers during Diwali turned the festival nights into fear-inducing experiences for children with autism. Veteran disability rights activist from Bengal, Shampa Sengupta, writes about the sensory distress, medical challenges and difficulties faced by children with autism and other disabilities and the anxiety of their families during the festivities.

Kukur Tihar and Diwali: The precarious in-betweenness of dogs

Kukur Tihar, Diwali: While Nepal honours its dogs with marigold garlands and ritual offerings, India's Diwali celebrations expose a troubling contradiction. Illegal firecrackers leave dogs, cats and birds terrified, raising questions about animal welfare and whether compassion extends beyond religious rituals.

Fireworks fade, trauma lingers: How Diwali firecrackers leave animals and birds wounded?

Diwali may bring celebrations for humans, but for animals and birds, firecrackers mean terror, injuries and displacement. From a missing pet dog in Kolkata to injured wildlife and traumatised street animals, rescuers recount the devastating consequences of festive fireworks.

Super El Niño: Is the world ready for a ‘Godzilla’ climate crisis?

Super El Niño 2026: In October, sea-surface temperature anomalies in the Niño 3.4 region are forecast to exceed 3.8°C, surpassing the 2015–16 record. The WMO warns that its effects could continue into 2027. India faces a 13% monsoon rainfall deficit, drought across 39.8% of agricultural land and a potential 4% decline in crop production.

India tops the world: 50 million Indian children lack school sanitation

Around 50 million Indian children lacked school sanitation in 2025, highlighting the gap between having toilets and having usable facilities.